Analysts Unconvinced By Sanofi Best-In-Class Claims For Sarclisa

Much Ground To Make Up On J&J's Darzalex

 
• By Kevin Grogan
Sanofi_France
Sanofi highlighted Sarclisa at virtual oncology briefing • Source: Shutterstock

More from Anticancer

More from Therapeutic Category